Target intelligence / Profile preview

Quorum-sensing system of Pseudomonas aeruginosa (QS system)

Target
QS system
Molecular classification
Transcription factor, Enzyme, Receptor
01

Overview

The Quorum-sensing (QS) system of Pseudomonas aeruginosa is a complex, hierarchical regulatory network that allows the bacterium to coordinate gene expression based on population density. It primarily consists of four interconnected pathways—Las, Rhl, Pqs, and Iqs—which utilize signaling molecules called autoinducers to regulate the production of virulence factors and the formation of biofilms (Papenfort & Bassler, 2016). In clinical settings, this system is a critical driver of chronic infections, particularly in patients with cystic fibrosis or compromised immune systems, as it enables the pathogen to evade host defenses and resist conventional antibiotics (Lee & Zhang, 2015). Therapeutic strategies targeting the QS system, known as quorum quenching, aim to attenuate bacterial virulence without necessarily killing the bacteria, thereby reducing the selective pressure for resistance (Moradali et al., 2017). Experimental drugs and natural compounds often act by inhibiting the synthesis of autoinducers or by competitively binding to receptor proteins like LasR and PqsR to prevent the activation of downstream pathogenic pathways (Schoenfelder et al., 2018). This approach represents a promising "anti-virulence" strategy to manage multi-drug resistant Pseudomonas infections.

Other names
Las/Rhl/Pqs/Iqs systemPseudomonas cell-to-cell communication networkLasR-LasI systemRhlR-RhlI systemPqsR-PqsABCD systemMvfR-regulated pathway
02

Mechanism of action

Quorum quenching via competitive antagonism of receptors (LasR, RhlR, PqsR), inhibition of autoinducer synthases, or enzymatic degradation of signaling molecules.

03

Biological functions

Signal transductionBiofilm formationVirulence factor productionGene regulationCell-to-cell communication
04

Disease associations

Infection
05

Safety considerations

Potential for resistance development through mutations in regulator genesImpact on host-microbiome homeostasisDifficulty in achieving therapeutic concentrations within dense biofilmsPotential for cheater bacterial populations to bypass inhibition
06

Interacting drugs

Azithromycin

4 more in the full profile.

07

Biomarkers

N-3-oxo-dodecanoyl-L-homoserine lactone (3-oxo-C12-HSL)N-butyryl-L-homoserine lactone (C4-HSL)2-heptyl-3-hydroxy-4-quinolone (PQS)PyocyaninLasB elastase

Beyond the preview

Go deeper on Quorum-sensing system of Pseudomonas aeruginosa (QS system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quorum-sensing system of Pseudomonas aeruginosa (QS system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call